Ten year review of melanoma with regression by Shen, Nicole & Nicholl, Michael
POSTER 13
TEN YEAR REVIEW OF MELANOMA WITH REGRESSION
Nicole Shen (M2)
Michael Nicholl, MD
(Paul Dale, MD)
Ellis Fischel Cancer Center
 
Melanoma with regression is seen in 10-35% of cutaneous melanomas.  We retrospectively 
reviewed our experience with these unusual melanomas. Between the ten year period from 
January 1999-Janurary 1010, 192 patients (aged 23-89) presented with primary melanoma of 
which 11 (6%) had evidence of regression.  The median age was 54 (range of 38-78) with 6 
males and 5 females. Primary location was truncal in 7 patients (64%), extremity in 3 patients 
(27%), and head and neck in 1 patient (9%).  The median Breslow depth was 0.87 mm. (range 
0.37-1.8) and the median Clarks level was 3 (range 2-4), only 3 patients had tumors >1.0mm. 
Ulceration was present in 1/11, no angiolymphatic involvement was identified, and 8/11 had 
minimal to no mitotic figures.  Eight patients underwent sentinel node biopsy and 1/8 (12.5%) 
was positive and the only node positive on completion dissection.  Median followup was 17 
months (range 5-103 months) with no recurrence and no melanoma related deaths.  Regression 
in primary melanomas is rare with only 6% of our melanoma patients.  A relatively high number 
of these patients 2/11 (18%) presented with nodal metastasis even though these patients’ primary 
were <1mm in depth.  Neither of these patients’ primary exhibited poor prognostic factors such 
as ulceration, angiolymphatic invasion or a high mitotic index.  Thorough clinical evaluation and 
sentinel lymph node biopsy should be considered in patients with evidence of regression of their 
primary to detect lymphatic metastasis and institute appropriate therapy to improve survival. 
